2.50Open2.50Pre Close0 Volume4 Open Interest17.50Strike Price0.00Turnover151.84%IV14.14%PremiumDec 20, 2024Expiry Date0.03Intrinsic Value100Multiplier20DDays to Expiry2.47Extrinsic Value100Contract SizeAmericanOptions Type-0.4278Delta0.0622Gamma6.99Leverage Ratio-0.0596Theta-0.0051Rho-2.99Eff Leverage0.0163Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet